Symbol="SLS"
AssetType="Common Stock"
Name="Sellas Life Sciences Group Inc"
Description="SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the United States. The company is headquartered in New York, New York."
CIK="1390478"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="310 N. STATE STREET, SUITE 208, LAKE OSWEGO, OR, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="40254000"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.171"
DividendPerShare="0"
DividendYield="0"
EPS="-1.46"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.909"
ReturnOnEquityTTM="-3.019"
RevenueTTM="0"
GrossProfitTTM="900000"
DilutedEPSTTM="-1.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.825"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="47.76"
PriceToBookRatio="3.792"
EVToRevenue="27.45"
EVToEBITDA="-0.622"
Beta="2.289"
num_52WeekHigh="5.58"
num_52WeekLow="1.17"
num_50DayMovingAverage="1.627"
num_200DayMovingAverage="2.163"
SharesOutstanding="28347900"
DividendDate="2019-11-08"
ExDividendDate="None"
symbol="SLS"
open="1.41"
high="1.60"
low="1.41"
price="1.51"
volume="264387.00"
latest_trading_day="2023-08-18"
previous_close="1.42"
change="0.09"
change_percent="6.3380%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="174993"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="94"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_negative_thumbnail_id_2="1104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0137.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="980"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0142.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
